Therapy

TherapeuticsMD

$1.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+3.85%) As of 4:04 PM UTC today

Why Robinhood?

You can buy or sell TherapeuticsMD and other stocks, options, and ETFs commission-free!

About TXMD

TherapeuticsMD, Inc. Common Stock, also called TherapeuticsMD, is a pharmaceutical company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL. The listed name for TXMD is TherapeuticsMD, Inc. Common Stock.

CEO
Robert G. Finizio
Employees
348
Headquarters
Boca Raton, Florida
Founded
1907
Market Cap
423.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.58M
High Today
$1.52
Low Today
$1.43
Open Price
$1.50
Volume
2.69M
52 Week High
$2.93
52 Week Low
$0.853

Collections

TXMD Earnings

-$0.21
-$0.14
-$0.07
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 18, Pre-Market

You May Also Like

CTIB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure